🇮🇳 India Daybook: SBI Net Profit Surges 14% to ₹23,038 Cr, MCX & NSE Post Robust Q2 Numbers

📍 FINANCIAL RESULTS & EARNINGS

• State Bank of India (SBI): The country’s largest public-sector lender reported a 14% year-on-year increase in standalone net profit to ₹23,038 crore for Q2 FY27, underpinned by steady loan expansion and improving asset quality metrics.
• National Stock Exchange (NSE): Consolidated net profit jumped 23% YoY to ₹2,578 crore for the July–September quarter, up from ₹2,098 crore a year earlier. Operating revenue advanced 10.6% YoY to ₹4,067 crore, while operating EBITDA rose 107% YoY to ₹3,079 crore with an EBITDA margin of 76%.
• Multi Commodity Exchange of India (MCX): The commodity derivatives exchange delivered a 10% YoY climb in net profit to ₹454.6 crore. Operating revenue increased 14% YoY to ₹800 crore, while EBITDA improved 24% to ₹612 crore, expanding its operating margin to 76.4%.
• Lloyds Metals & Energy: The company posted strong Q2 results, with consolidated net profit surging 88% YoY to ₹1,045.62 crore and revenue jumping 55.3% YoY to ₹5,672.53 crore.
• Bata India: The footwear retailer recorded a 31.2% YoY rise in consolidated net profit to ₹18.1 crore for Q2, accompanied by a 7.5% YoY rise in revenue to ₹861.7 crore.
• Yatharth Hospitals: Consolidated net profit advanced 17.5% YoY to ₹48.45 crore for the September quarter, supported by healthy inpatient admissions and operational bed utilization.
• Zydus Wellness: The consumer products player swung back into black, posting a consolidated net profit of ₹5.1 crore against a net loss of ₹52.8 crore in the corresponding quarter of the previous fiscal.
• Linde India: Net profit dropped 30.5% YoY to ₹119 crore due to margin contraction, even as consolidated revenue rose 12.3% YoY to ₹723 crore.
• SKF India: Reported a 50.5% YoY slide in net profit to ₹52 crore, with quarterly consolidated top line declining 54.5% YoY to ₹596 crore.
• Evonile Pharma: Formerly Novartis India, the company registered a consolidated net loss of ₹77.54 crore for the second quarter, hit by exceptional provisions and lower turnover.

📍 MERGERS & ACQUISITIONS

• IDBI Bank / Fairfax Financial Holdings: Canadian investment firm Fairfax affirmed its selection by the Government of India as the strategic buyer for a 60.72% controlling stake in IDBI Bank for approximately ₹52,880 crore ($5.6 billion), setting up the final clearance stages for the lender's strategic disinvestment.
• HRV Pharma: The Hyderabad-based pharmaceutical company announced the complete takeover of German wholesaler Phatebo GmbH to expand distribution of clinical trial supplies and build out finished formulation operations across Europe.

📍 REGULATORY ACTIONS

• Axis Mutual Fund Front-Running Case: The Securities and Exchange Board of India (SEBI) imposed an aggregate penalty of ₹40 lakh on Woodstock Broking and Marfatia Stock Broking for permitting unauthorized trading terminal access used in overseas front-running trades.